Learn More, Access Our New Resources and Take Action! This month, we’re supporting the 26.8 million people in the U.S. living ...

Zongertinib conferred a clinically meaningful benefit in patients with previously treated, advanced, HER2-mutant NSCLC in a phase 1 trial.

On the heels of President Donald Trump’s Monday announcement of an executive order that will slash prescription drug prices ...

Special meeting of stockholders to vote on Merger to take place on May 28, 2025 WALTHAM, Mass., May 13, 2025 (GLOBE NEWSWIRE) ...